Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
The proposed, $63 billion transaction is the latest deal in an industry where it can be cheaper to buy the science of another company than develop products.
A bit of context to simmer on following the big deal between Caesars and Eldorado.
Is prohibition the real factor propping up projections for demand and pricing in the cannabis market?
Oracle tells investors it can regain the crown it once held among enterprises and end-users, but some aren't so sure.
Is the bad news for Oracle all over?
The healthcare app creator reportedly shelves a Hong Kong listing in favor of "China's Nasdaq" due to data privacy and transparency concerns.
Will Slack help set a new trend for IPO strategy among red-hot technology companies?
Is Libra the next tectonic shift in tech? Is it even a cryptocurrency at all?